Stock Events

Stock Events

Antibe Therapeutics 

€2.44
0
-€0-0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
2.44
52W Low
2.44
Volume
-
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4B70.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes in the inflammation and pain management sector, directly challenging Antibe's core market with its range of anti-inflammatory and pain relief medications.
Pfizer
PFE
Mkt Cap149.77B
Pfizer has a broad portfolio of drugs that address similar therapeutic areas as Antibe, including pain management and inflammation, making it a direct competitor.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division Janssen, offers products that compete in the same space as Antibe's, particularly in the areas of pain relief and anti-inflammatory treatments.
Novartis
NVS
Mkt Cap279.67B
Novartis provides a wide array of medications, including those for pain and inflammation, directly competing with Antibe Therapeutics in these therapeutic areas.
Merck
MRK
Mkt Cap277.02B
Merck operates in various therapeutic areas, including pain management and inflammation, offering competitive products to those of Antibe Therapeutics.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline has a diverse pharmaceutical portfolio that includes treatments for pain and inflammation, positioning it as a competitor to Antibe.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb offers several drugs that target the same therapeutic areas as Antibe, making it a competitor in the market for anti-inflammatory and pain management solutions.
AMGEN
AMGN
Mkt Cap178B
Amgen focuses on innovative therapeutics, including those for inflammation and pain, which competes with Antibe's research and product offerings.
Biogen
BIIB
Mkt Cap27.62B
Biogen's focus on novel therapies, including those for inflammatory diseases, places it in direct competition with Antibe Therapeutics.
Sanofi
SNY
Mkt Cap110.4B
Sanofi has a broad portfolio that includes treatments for pain and inflammation, directly competing with Antibe in these therapeutic areas.

About

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead compound is Otenaproxesul, an NSAID that releases hydrogen sulfide for treating post-operative pain, migraine, acute musculoskeletal pain, dysmenorrhea, gout, and dental pain. In addition, its products comprise ATB-352, which is in preclinical stage for acute pain. The company was incorporated in 2009 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Daniel Marcel Legault J.D., L.L.B.
Employees
11
Country
Canada
ISIN
CA0370255097

Listings

STU
DE
4B70.STU

0 Comments

Share your thoughts

FAQ

What is Antibe Therapeutics stock price today?▼
The current price of 4B70.STU is €2.44 EUR — it has decreased by -0% in the past 24 hours. Watch Antibe Therapeutics stock price performance more closely on the chart.
What is Antibe Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Antibe Therapeutics stocks are traded under the ticker 4B70.STU.
Is Antibe Therapeutics stock price growing?▼
4B70.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Antibe Therapeutics has showed a +0% increase.
How many employees does Antibe Therapeutics have?▼
As of May 06, 2026, the company has 11 employees.
In which sector is Antibe Therapeutics located?▼
Antibe Therapeutics operates in the Health & Wellness sector.
When did Antibe Therapeutics complete a stock split?▼
Antibe Therapeutics has not had any recent stock splits.
Where is Antibe Therapeutics headquartered?▼
Antibe Therapeutics is headquartered in Toronto, Canada.